Real-time assessment of bacteriophage T3-derived antimicrobial activity against planktonic and biofilm-embedded Escherichia coli by isothermal microcalorimetry

Research in Microbiology

Volumn 169, Issue 9, 2018, Pages 515-521

  Tkhilaishvili, Tamta ^a,b   Di Luca, Mariagrazia ^a,b,c   Abbandonato, Gerardo ^c   Maiolo, Elena Maryka ^a,b   Klatt, Ann Brit ^a,b   Reuter, Monika ^a   Möncke Buchner, Elisabeth ^a   Trampuz, Andrej ^a,b  

^a BERLIN INSTITUTE OF HEALTH   (Germany)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^c ISTITUTO NANOSCIENZE CNR   (Italy)

Author keywords

Antimicrobials; Bacterial biofilm; Calorimetry; Lytic activity; Phage therapy; Phage host interplay

Indexed keywords

ARTICLE; BACTERIAL CELL; BACTERIAL GROWTH; BACTERIAL STRAIN; BIOFILM; CONTROLLED STUDY; ENTEROBACTERIA PHAGE T3; ESCHERICHIA COLI; GROWTH INHIBITION; IN VITRO STUDY; ISOTHERMAL MICROCALORIMETRY; MICROCALORIMETRY; NONHUMAN; ORGANISMAL INTERACTION; PHAGE THERAPY; PHAGE TITER; PLANKTON; PRIORITY JOURNAL; THERMOGENESIS; CALORIMETRY; COMPUTER SYSTEM; GROWTH, DEVELOPMENT AND AGING; MICROBIAL SENSITIVITY TEST; PATHOGENICITY; PHYSIOLOGY; PROCEDURES; VIROLOGY;

ANTIINFECTIVE AGENT;

ANTI-BACTERIAL AGENTS; BACTERIOPHAGE T3; BIOFILMS; CALORIMETRY; COMPUTER SYSTEMS; ESCHERICHIA COLI; MICROBIAL SENSITIVITY TESTS;

EID: 85049314739     PISSN: 09232508     EISSN: 17697123     Source Type: Journal    
DOI: 10.1016/j.resmic.2018.05.010     Document Type: Article

References (40)

1. Laxminarayan, R., Duse, A., Wattal, C., Zaidi, A.K., Wertheim, H.F., Sumpradit, N., et al. Antibiotic resistance-the need for global solutions. Lancet Infect Dis 13 (2013), 1057–1098.
2. Lebeaux, D., Ghigo, J.M., Beloin, C., Biofilm-related infections: bridging the gap between clinical management and fundamental aspects of recalcitrance toward antibiotics. Microbiol Mol Biol Rev 78 (2014), 510–543.
3. Davies, D., Understanding biofilm resistance to antibacterial agents. Nat Rev Drug Discov, 2, 2003, 114.
4. Zimmerli, W., Trampuz, A., Ochsner, P.E., Prosthetic-joint infections. N Engl J Med 351 (2004), 1645–1654.
5. Wu, H., Moser, C., Wang, H.-Z., Høiby, N., Song, Z.-J., Strategies for combating bacterial biofilm infections. Int J Oral Sci, 7, 2014, 1.
6. Sulakvelidze, A., Alavidze, Z., Morris, J.G., Bacteriophage therapy. Antimicrob Agents Chemother 45 (2001), 649–659.
7. Viertel, T.M., Ritter, K., Horz, H.P., Viruses versus bacteria-novel approaches to phage therapy as a tool against multidrug-resistant pathogens. J antimicrob chemother 69 (2014), 2326–2336.
8. Wittebole, X., De Roock, S., Opal, S.M., A historical overview of bacteriophage therapy as an alternative to antibiotics for the treatment of bacterial pathogens. Virulence 5 (2014), 226–235.
9. Kutateladze, M., Adamia, R., Phage therapy experience at the Eliava Institute. Med Maladies Infect 38 (2008), 426–430.
10. Abedon, S.T., Kuhl, S.J., Blasdel, B.G., Kutter, E.M., Phage treatment of human infections. Bacteriophage 1 (2011), 66–85.
11. Atterbury, R.J., Bacteriophage biocontrol in animals and meat products. Microbial biotechnology 2 (2009), 601–612.
12. Jennes, S., Merabishvili, M., Soentjens, P., Pang, K.W., Rose, T., Keersebilck, E., et al. Use of bacteriophages in the treatment of colistin-only-sensitive Pseudomonas aeruginosa septicaemia in a patient with acute kidney injury—a case report. Crit Care, 21, 2017, 129.
13. Speck, P., Smithyman, A., Safety and efficacy of phage therapy via the intravenous route. FEMS Microbiol Lett, 363, 2016.
14. Chan, B.K., Abedon, S.T., Loc-Carrillo, C., Phage cocktails and the future of phage therapy. Future Microbiol 8 (2013), 769–783.
15. Mendes, J.J., Leandro, C., Corte-Real, S., Barbosa, R., Cavaco-Silva, P., Melo-Cristino, J., et al. Wound healing potential of topical bacteriophage therapy on diabetic cutaneous wounds. Wound Repair Regen - Off Pub Wound Heal Soc Eur Tissue Repair Soc 21 (2013), 595–603.
16. Goodridge, L.D., Bacteriophage biocontrol of plant pathogens: fact or fiction?. Trends Biotechnol 22 (2004), 384–385.
17. Keen, E.C., Phage therapy: concept to cure. Front Microbiol, 3, 2012, 238.
18. Parmar, K.M., Gaikwad, S.L., Dhakephalkar, P.K., Kothari, R., Singh, R.P., Intriguing interaction of bacteriophage-host association: an understanding in the era of omics. Front Microbiol, 8, 2017, 559.
19. Kropinski, A.M., Mazzocco, A., Waddell, T.E., Lingohr, E., Johnson, R.P., Enumeration of bacteriophages by double agar overlay plaque assay. Methods Mol Biol 501 (2009), 69–76.
20. Neguţ A.C., Săndulescu, O., Popa, M., Streinu-Cercel, A., Alavidze, Z., Berciu, I., et al. Experimental approach for bacteriophage susceptibility testing of planktonic and sessile bacterial populations – study protocol. Germs 4 (2014), 92–96.
21. Braissant, O., Wirz, D., Gopfert, B., Daniels, A.U., Use of isothermal microcalorimetry to monitor microbial activities. FEMS Microbiol Lett 303 (2010), 1–8.
22. Oliva, A., Furustrand Tafin, U., Maiolo, E.M., Jeddari, S., Betrisey, B., Trampuz, A., Activities of fosfomycin and rifampin on planktonic and adherent Enterococcus faecalis strains in an experimental foreign-body infection model. Antimicrob Agents Chemother 58 (2014), 1284–1293.
23. Maiolo, E.M., Furustrand Tafin, U., Borens, O., Trampuz, A., Activities of fluconazole, caspofungin, anidulafungin, and amphotericin B on planktonic and biofilm Candida species determined by microcalorimetry. Antimicrob Agents Chemother 58 (2014), 2709–2717.
24. Guosheng, L., Yi, L., Xiangdong, C., Peng, L., Ping, S., Songsheng, Q., Study on interaction between T4 phage and Escherichia coli B by microcalorimetric method. J Virol Methods 112 (2003), 137–143.
25. Maskow, T., Kiesel, B., Schubert, T., Yong, Z., Harms, H., Yao, J., Calorimetric real time monitoring of lambda prophage induction. J Virol Methods 168 (2010), 126–132.
26. Morais, F.M., Buchholz, F., Maskow, T., Chip calorimetry for evaluation of biofilm treatment with biocides, antibiotics, and biological agents. Methods Mol Biol 1147 (2014), 267–275.
27. Kruger, D.H., Schroeder, C., Hansen, S., Rosenthal, H.A., Active protection by bacteriophages T3 and T7 against E. coli B- and K-specific restriction of their DNA. Mol Gen Genet 153 (1977), 99–106.
28. Gonzalez Moreno, M., Trampuz, A., Di Luca, M., Synergistic antibiotic activity against planktonic and biofilm-embedded Streptococcus agalactiae, Streptococcus pyogenes and Streptococcus oralis. J Antimicrob Chemother 72 (2017), 3085–3092.
29. Di Luca, M., Navari, E., Esin, S., Menichini, M., Barnini, S., Trampuz, A., et al. Advances in experimental medicine and biology. Donelli, G., (eds.) Advances in microbiology, infectious diseases and public health, vol 1057, 2017, Springer, 1–27, 10.1007/5584 2017 34.
30. Butini, M.E., Cabric, S., Trampuz, A., Di Luca, M., In vitro anti-biofilm activity of a biphasic gentamicin-loaded calcium sulfate/hydroxyapatite bone graft substitute. Colloids Surf B Biointerfaces 161 (2017), 252–260.
31. Azeredo, J., Sutherland, I.W., The use of phages for the removal of infectious biofilms. Curr Pharmaceut Biotechnol 9 (2008), 261–266.
32. Motlagh, A.M., Bhattacharjee, A.S., Goel, R., Biofilm control with natural and genetically-modified phages. World J Microbiol Biotechnol, 32, 2016, 67.
33. Donlan, R.M., Biofilms: microbial life on surfaces. Emerg Infect Dis 8 (2002), 881–890.
34. Sutherland, I.W., Hughes, K.A., Skillman, L.C., Tait, K., The interaction of phage and biofilms. FEMS Microbiol Lett 232 (2004), 1–6.
35. Lewis, K., Riddle of biofilm resistance. Antimicrob Agents Chemother 45 (2001), 999–1007.
36. Waters, E.M., Neill, D.R., Kaman, B., Sahota, J.S., Clokie, M.R.J., Winstanley, C., et al. Phage therapy is highly effective against chronic lung infections with Pseudomonas aeruginosa. Thorax 72 (2017), 666–667.
37. Aksyuk, A.A., Rossmann, M.G., Bacteriophage assembly. Viruses 3 (2011), 172–203.
38. Payne, R.J.H., Jansen, V.A.A., Pharmacokinetic principles of bacteriophage therapy. Clin Pharmacokinet 42 (2003), 315–325.
39. Ryan, E.M., Alkawareek, M.Y., Donnelly, R.F., Gilmore, B.F., Synergistic phage-antibiotic combinations for the control of Escherichia coli biofilms in vitro. FEMS Immunol Med Microbiol 65 (2012), 395–398.
40. Henry, M., Lavigne, R., Debarbieux, L., Predicting in vivo efficacy of therapeutic bacteriophages used to treat pulmonary infections. Antimicrob Agents Chemother 57 (2013), 5961–5968.